From October 21, 2021 to December 31, 2021, the company has repurchased 3,607,950 shares, representing 1% for CNY 199.98 million. With this, the company has completed the repurchase of 3,607,950 shares, representing 1% for CNY 199.98 million under the buyback announced on October 22, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.64 CNY | +1.85% |
|
+2.32% | -9.77% |
12/06 | Sansure Biotech's Tuberculosis Diagnostic Kit Gets EU Certification | MT |
26/04 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.77% | 1.38B | |
-5.77% | 12.14B | |
+96.15% | 8.43B | |
-18.38% | 6.91B | |
+9.93% | 5.93B | |
-21.66% | 3.57B | |
+5.36% | 2.53B | |
+41.54% | 2.45B | |
+14.23% | 2.94B | |
-18.43% | 1.59B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 22, 2021.